Michael B. Jebsen
2021
In 2021, Michael B. Jebsen earned a total compensation of $980.4K as Former President and Chief Financial Officer at Tenax Therapeutics, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,858 |
|---|---|
| Option Awards | $105,695 |
| Salary | $321,401 |
| Other | $403,421 |
| Total | $980,375 |
Jebsen received $403.4K in other compensation, accounting for 41% of the total pay in 2021.
Jebsen also received $149.9K in non-equity incentive plan, $105.7K in option awards and $321.4K in salary.
Rankings
In 2021, Michael B. Jebsen's compensation ranked 8,840th out of 12,406 executives tracked by ExecPay. In other words, Jebsen earned more than 28.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,840 out of 12,406 | 29th |
Division Manufacturing | 3,914 out of 5,494 | 29th |
Major group Chemicals And Allied Products | 1,726 out of 2,369 | 27th |
Industry group Drugs | 1,535 out of 2,090 | 27th |
Industry Pharmaceutical Preparations | 1,141 out of 1,537 | 26th |
Source: SEC filing on April 28, 2022.
Jebsen's colleagues
We found four more compensation records of executives who worked with Michael B. Jebsen at Tenax Therapeutics in 2021.